Oleg Gluz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oleg gluz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oleg Gluz Today - Breaking & Trending Today

Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer

Beyond genomic testing, endocrine therapy response should be used to determine whether patients with hormone receptor–positive, HER2-negative, N0-1 early breast cancer. ....

San Antonio , United States , West German , Oleg Gluz , German Study Group , Antonio Breast Cancer , West German Study Group , Adaptcycle Trial , The Addition Of Ovarian Function Suppression To Endocrine Therapy , Patients With Hormone Receptor Positive , Er2 Negative Early Breast Cancer ,

Consider Endocrine Therapy Responses When Planning Chemo in Breast Cancer Subset

Results from the ADAPTcycle trial found that endocrine therapy plus ovarian suppression can generate high response rates in patients with HR-positive, early breast cancer, regardless of age. ....

San Antonio , United States , West German , Oleg Gluz , German Study Group , Antonio Breast Cancer , West German Study Group , Breast Cancer ,

Agendia, Inc.: Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer

Agendia partners with the West German Study Group to determine the benefit of ovarian function suppression, potentially reducing overtreatment with chemotherapy Trial reinforces Agendia's ....

West German , Dennis Riedl , William Audeh , Oleg Gluz , Kerry Harrington , German Study Group , Agendia Inc , University Of Cologne , Breast Center Niederrhein , West German Study Group , Mammaprint Low Risk , Scientific Director , Hospital Bethesda , Chief Medical Officer ,